PRNewsWire
13 Jul 2026, 08:47 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
The lawsuit alleges that Erasca made false and misleading statements regarding its ERAS-0015 product and risks of patent violations. — Claims of misleading data or patent risks regarding a core product (ERAS-0015) strike at the fundamental value and regulatory viability of a biotech company.
-0.60Erasca, Inc. (ERAS) is facing a class action lawsuit alleging violations of the Securities Exchange Act of 1934. — Securities litigation creates legal uncertainty and potential financial liabilities, which typically weigh on a company's stock price.
-0.40Which stocks this story touches
The company is being sued for securities law violations in a class action lawsuit.
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is being sued for securities law violations in a class action lawsuit.
The company is facing a class action lawsuit alleging false and misleading statements regarding ERAS-0015.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
1h ago
